Carbatrol
NDC 54092-172, carbamazepine, capsule, extended release, from Takeda Pharmaceuticals America, Inc..
- Product NDC
- 54092-172
- Status
- Listed
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020712
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/54092-172 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARBAMAZEPINE200 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 54092-172-12 | 54092017212 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-172-12) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/bc03e499-5bac-4293-bff4-6864153a624dNADAC price for package 54092017212
GET /v1/drugs/nadac/54092017212
Use it
Look up 54092-172 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/54092-172 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 54092-172. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.